Negative trials in nonalcoholic steatohepatitis: Why they happen and what they teach us

被引：15

作者：

Clark, JM

Brancati, FL

机构：

[1] Johns Hopkins Univ, Dept Med, Baltimore, MD USA

[2] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA

来源：

HEPATOLOGY | 2004年 / 39卷 / 03期

关键词：

D O I：

10.1002/hep.20121

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：602 / 603

页数：2

共 8 条

[1]

CUCCHERINI B, 1983, J LAB CLIN MED, V102, P370

[2] METHODS FOR ASSESSING WHETHER CHANGE DEPENDS ON INITIAL-VALUE [J].

HAYES, RJ .

STATISTICS IN MEDICINE, 1988, 7 (09) :915-927

[3]

HEINS M, 1995, EUR J CLIN CHEM CLIN, V33, P231

[4]

Kleiner DE, 2003, HEPATOLOGY, V38, p233A

[5] Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: Results of a randomized trial [J].

Lindor, KD ;

Kowdley, KV ;

Heathcote, EJ ;

Harrison, ME ;

Jorgensen, R ;

Angulo, P ;

Lymp, JF ;

Burgart, L ;

Colin, P .

HEPATOLOGY, 2004, 39 (03) :770-778

[6]

ONO T, 1981, CLIN CHEM, V27, P35

[7] BLOOD-PRESSURE REDUCTIONS - CORRECTING FOR REGRESSION TO THE MEAN [J].

SHEPARD, DS ;

FINISON, LJ .

PREVENTIVE MEDICINE, 1983, 12 (02) :304-317

[8]

Younossi ZM, 1998, MODERN PATHOL, V11, P560

← 1 →